HeartWare to float new shares
Thursday, 05 June, 2008
HeartWare (ASX: HTW) will hold an extraordinary general meeting next month to receive shareholder permission to float up to 70 million new shares.
The shares will be offered privately to professional investors in Australia and the US, and will be sold at $0.50 cents a share.
The purpose of the listing is to raise $30 million in capital. HeartWare, which manufactures miniature medical devices, will offer a share purchase plan to allow current stockholders the opportunity to purchase the new shares at the same price as that offered to the private investors.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
